CN115223658A - 一种基于二代测序的微卫星不稳定性检测方法 - Google Patents
一种基于二代测序的微卫星不稳定性检测方法 Download PDFInfo
- Publication number
- CN115223658A CN115223658A CN202110427488.6A CN202110427488A CN115223658A CN 115223658 A CN115223658 A CN 115223658A CN 202110427488 A CN202110427488 A CN 202110427488A CN 115223658 A CN115223658 A CN 115223658A
- Authority
- CN
- China
- Prior art keywords
- msi
- sample
- sites
- detection
- detected
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 208000032818 Microsatellite Instability Diseases 0.000 title claims abstract description 142
- 238000001514 detection method Methods 0.000 title claims abstract description 111
- 238000007481 next generation sequencing Methods 0.000 title claims abstract description 25
- 238000012163 sequencing technique Methods 0.000 claims abstract description 51
- 108091092878 Microsatellite Proteins 0.000 claims abstract description 29
- 238000003908 quality control method Methods 0.000 claims abstract description 8
- 239000000523 sample Substances 0.000 claims description 142
- 238000000034 method Methods 0.000 claims description 47
- 206010028980 Neoplasm Diseases 0.000 claims description 35
- 201000011510 cancer Diseases 0.000 claims description 27
- 238000012360 testing method Methods 0.000 claims description 20
- 239000003153 chemical reaction reagent Substances 0.000 claims description 9
- 230000008569 process Effects 0.000 claims description 3
- 239000013074 reference sample Substances 0.000 claims description 3
- 238000004364 calculation method Methods 0.000 abstract description 4
- 206010009944 Colon cancer Diseases 0.000 description 29
- 208000001333 Colorectal Neoplasms Diseases 0.000 description 29
- 206010014759 Endometrial neoplasm Diseases 0.000 description 18
- 241000894007 species Species 0.000 description 18
- 206010014733 Endometrial cancer Diseases 0.000 description 17
- 230000000052 comparative effect Effects 0.000 description 15
- 208000005718 Stomach Neoplasms Diseases 0.000 description 12
- 206010017758 gastric cancer Diseases 0.000 description 12
- 201000011549 stomach cancer Diseases 0.000 description 12
- 230000035945 sensitivity Effects 0.000 description 7
- 238000009169 immunotherapy Methods 0.000 description 6
- 238000007796 conventional method Methods 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 5
- 238000004458 analytical method Methods 0.000 description 3
- 238000011056 performance test Methods 0.000 description 3
- 238000004393 prognosis Methods 0.000 description 3
- 238000007480 sanger sequencing Methods 0.000 description 3
- 108091081062 Repeated sequence (DNA) Proteins 0.000 description 2
- 238000002512 chemotherapy Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000000556 factor analysis Methods 0.000 description 2
- 230000004907 flux Effects 0.000 description 2
- 230000009466 transformation Effects 0.000 description 2
- 238000012795 verification Methods 0.000 description 2
- 206010004593 Bile duct cancer Diseases 0.000 description 1
- 229940045513 CTLA4 antagonist Drugs 0.000 description 1
- 108020004414 DNA Proteins 0.000 description 1
- 230000004543 DNA replication Effects 0.000 description 1
- GHASVSINZRGABV-UHFFFAOYSA-N Fluorouracil Chemical compound FC1=CNC(=O)NC1=O GHASVSINZRGABV-UHFFFAOYSA-N 0.000 description 1
- 241000258241 Mantis Species 0.000 description 1
- 206010033128 Ovarian cancer Diseases 0.000 description 1
- 206010061535 Ovarian neoplasm Diseases 0.000 description 1
- 206010061902 Pancreatic neoplasm Diseases 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 208000037844 advanced solid tumor Diseases 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 208000026900 bile duct neoplasm Diseases 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 229940044683 chemotherapy drug Drugs 0.000 description 1
- 208000006990 cholangiocarcinoma Diseases 0.000 description 1
- 238000003759 clinical diagnosis Methods 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000012217 deletion Methods 0.000 description 1
- 230000037430 deletion Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 229960002949 fluorouracil Drugs 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 238000012165 high-throughput sequencing Methods 0.000 description 1
- 238000003364 immunohistochemistry Methods 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 208000015486 malignant pancreatic neoplasm Diseases 0.000 description 1
- 230000033607 mismatch repair Effects 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 201000002528 pancreatic cancer Diseases 0.000 description 1
- 208000008443 pancreatic carcinoma Diseases 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000011269 treatment regimen Methods 0.000 description 1
Classifications
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B30/00—ICT specially adapted for sequence analysis involving nucleotides or amino acids
Landscapes
- Physics & Mathematics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Analytical Chemistry (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Bioinformatics & Computational Biology (AREA)
- Biotechnology (AREA)
- Evolutionary Biology (AREA)
- General Health & Medical Sciences (AREA)
- Medical Informatics (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Theoretical Computer Science (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Description
Claims (18)
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110427488.6A CN115223658B (zh) | 2021-04-20 | 2021-04-20 | 一种基于二代测序的微卫星不稳定性检测方法 |
EP22790777.1A EP4328920A1 (en) | 2021-04-20 | 2022-03-22 | Microsatellite instability detection method based on second-generation sequencing |
PCT/CN2022/082252 WO2022222668A1 (zh) | 2021-04-20 | 2022-03-22 | 一种基于二代测序的微卫星不稳定性检测方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110427488.6A CN115223658B (zh) | 2021-04-20 | 2021-04-20 | 一种基于二代测序的微卫星不稳定性检测方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN115223658A true CN115223658A (zh) | 2022-10-21 |
CN115223658B CN115223658B (zh) | 2023-04-28 |
Family
ID=83604067
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110427488.6A Active CN115223658B (zh) | 2021-04-20 | 2021-04-20 | 一种基于二代测序的微卫星不稳定性检测方法 |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP4328920A1 (zh) |
CN (1) | CN115223658B (zh) |
WO (1) | WO2022222668A1 (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN117809744A (zh) * | 2023-04-21 | 2024-04-02 | 苏州吉因加生物医学工程有限公司 | 一种筛选msi特征位点的方法、装置和存储介质 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109207594A (zh) * | 2018-09-29 | 2019-01-15 | 广州燃石医学检验所有限公司 | 一种基于二代测序的通过血浆检测微卫星稳定状态和基因组变化的方法 |
CN109637590A (zh) * | 2018-12-29 | 2019-04-16 | 西安交通大学 | 一种基于基因组测序的微卫星不稳定性检测系统及方法 |
CN110689921A (zh) * | 2019-12-10 | 2020-01-14 | 至本医疗科技(上海)有限公司 | 微卫星不稳定性检测装置、计算机设备及计算机存储介质 |
CN112687333A (zh) * | 2020-12-24 | 2021-04-20 | 北京吉因加医学检验实验室有限公司 | 一种泛癌种的单样本微卫星不稳定性的分析方法和装置 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106755501B (zh) * | 2017-01-25 | 2020-11-17 | 广州燃石医学检验所有限公司 | 一种基于二代测序的同时检测微卫星位点稳定性和基因组变化的方法 |
CN107526944B (zh) * | 2017-09-06 | 2018-08-24 | 南京世和基因生物技术有限公司 | 一种微卫星不稳定性的测序数据分析方法、装置及计算机可读介质 |
CN110797078A (zh) * | 2020-01-06 | 2020-02-14 | 北京吉因加科技有限公司 | 微卫星不稳定位点筛选、分析模型的构建方法及装置 |
CN112365922B (zh) * | 2021-01-13 | 2021-06-15 | 臻和(北京)生物科技有限公司 | 用于检测msi的微卫星位点、其筛选方法及应用 |
-
2021
- 2021-04-20 CN CN202110427488.6A patent/CN115223658B/zh active Active
-
2022
- 2022-03-22 WO PCT/CN2022/082252 patent/WO2022222668A1/zh active Application Filing
- 2022-03-22 EP EP22790777.1A patent/EP4328920A1/en active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109207594A (zh) * | 2018-09-29 | 2019-01-15 | 广州燃石医学检验所有限公司 | 一种基于二代测序的通过血浆检测微卫星稳定状态和基因组变化的方法 |
CN109637590A (zh) * | 2018-12-29 | 2019-04-16 | 西安交通大学 | 一种基于基因组测序的微卫星不稳定性检测系统及方法 |
CN110689921A (zh) * | 2019-12-10 | 2020-01-14 | 至本医疗科技(上海)有限公司 | 微卫星不稳定性检测装置、计算机设备及计算机存储介质 |
CN112687333A (zh) * | 2020-12-24 | 2021-04-20 | 北京吉因加医学检验实验室有限公司 | 一种泛癌种的单样本微卫星不稳定性的分析方法和装置 |
Non-Patent Citations (2)
Title |
---|
TONGXIN WANG ET AL.: "MICROSATELLITE INSTABILITY PREDICTION OF UTERINE CORPUS ENDOMETRIAL CARCINOMA BASED ON H&E HISTOLOGY WHOLE-SLIDE IMAGING", 《2020 IEEE 17TH INTERNATIONAL SYMPOSIUM ON BIOMEDICAL IMAGING 》 * |
张琪等: "结直肠癌与微卫星不稳定的十个临床问题", 《肿瘤综合治疗电子杂志》 * |
Also Published As
Publication number | Publication date |
---|---|
EP4328920A1 (en) | 2024-02-28 |
WO2022222668A1 (zh) | 2022-10-27 |
CN115223658B (zh) | 2023-04-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN109207594B (zh) | 一种基于二代测序的通过血浆检测微卫星稳定状态和基因组变化的方法 | |
WO2018090298A2 (en) | Systems and methods for monitoring lifelong tumor evolution | |
CN109182525B (zh) | 一种微卫星生物标志物组合、检测试剂盒及其用途 | |
CN104781422B (zh) | 从血浆无创测定胎儿或肿瘤的甲基化组 | |
US20210104297A1 (en) | Systems and methods for determining tumor fraction in cell-free nucleic acid | |
CN107709636A (zh) | 用于诊断或检测肺癌的方法和组合物 | |
KR101501826B1 (ko) | 위암에 대한 예후 예측 모형의 제조방법 | |
WO2017112738A1 (en) | Methods for measuring microsatellite instability | |
CN115223658A (zh) | 一种基于二代测序的微卫星不稳定性检测方法 | |
CN112951325B (zh) | 一种用于癌症检测的探针组合的设计方法及其应用 | |
EP4334476A1 (en) | Methods and systems for analyzing nucleic acid molecules | |
CN112442540B (zh) | 微卫星不稳定性检测方法、标志物组合、试剂盒及应用 | |
US20240105281A1 (en) | Methods and Systems for Analyzing Nucleic Acid Molecules | |
CN112980950B (zh) | 一种检测直肠癌放化疗敏感性相关15基因突变位点的试剂盒及其应用 | |
CN111566229B (zh) | 乳腺癌分子分型及远处转移风险基因群及诊断产品和应用 | |
EP4281583A1 (en) | Heatrich-bs: heat enrichment of cpg-rich regions for bisulfite sequencing | |
TW202205301A (zh) | 微衛星不穩定性檢測方法及系統 | |
CN108342483B (zh) | 一组用于非超突变型结直肠癌分子分型的基因及其应用 | |
CN110564851A (zh) | 一组用于非超突变型直肠癌分子分型的基因及其应用 | |
CN112442538A (zh) | 用于结直肠癌患者基因检测的目标基因组以及相关的评估方法、用途和试剂盒 | |
CN115472294B (zh) | 预测小细胞转化肺腺癌患者转化速度的模型及其构建方法 | |
CN113764044B (zh) | 一种构建骨髓增生异常综合征进展基因预测模型的方法 | |
KR102323507B1 (ko) | 종양의 서브클론을 분석하는 방법 및 장치 | |
CN116377077A (zh) | 一种预测含铂类新辅助治疗对中晚期肿瘤患者适用性的试剂盒及系统 | |
Domingo Sabugo | Establishing methods for analysis of DNA methylation in breast cancer and cell-free circulating DNA |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB03 | Change of inventor or designer information |
Inventor after: Lin Chenghong Inventor after: Chen Shaohong Inventor after: Li Xuchao Inventor after: Jin Baolei Inventor after: Zhang Xiamei Inventor after: Dong Hua Inventor after: Ruan Li Inventor after: Zheng Limou Inventor before: Lin Chenghong Inventor before: Chen Shaohong Inventor before: Li Xuchao Inventor before: Jin Baolei Inventor before: Zhang Xiamei Inventor before: Dong Hua Inventor before: Ruan Li Inventor before: Zheng Limou |
|
CB03 | Change of inventor or designer information | ||
GR01 | Patent grant | ||
GR01 | Patent grant |